UBE2I

Across TCGA pan-cancer cohorts, UBE2I mass-spec protein differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of UBE2I’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where UBE2I mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types UBE2I is over-expressed in tumor.

LUAD are the cancer types where UBE2I tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2I mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.476	.014	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

UBE2I–LUAD

Open the LUAD breakdown →